Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-23,613
Closed -$867K 360
2017
Q3
$867K Sell
23,613
-4,392
-16% -$177K 0.1% 202
2017
Q2
$1.27M Buy
28,005
+108
+0.4% +$4.77K 0.14% 157
2017
Q1
$1.19M Sell
27,897
-10,466
-27% -$427K 0.11% 183
2016
Q4
$1.54M Buy
+38,363
New +$1.48M 0.16% 144
2016
Q2
Sell
-126,310
Closed -$4.36M 377
2016
Q1
$4.36M Buy
+126,310
New +$4.4M 0.47% 49
2014
Q1
Sell
-12,572
Closed -$281K 433
2013
Q4
$281K Buy
+12,572
New +$277K 0.02% 393

Other funds holding HOLX

Symphony Asset Management's HOLX Position: Q4 2017 in Review

Symphony Asset Management sold out of Hologic (HOLX) in Q4 2017, closing a stake of 23,613 shares — an estimated $867K sold.

Symphony Asset Management first reported a position in HOLX in Q4 2013 and held it in 6 quarters. The position peaked at $4.36M in Q1 2016. 472 funds tracked by Wall St. Rank hold HOLX as of Q4 2017.

  • Symphony Asset Management reported no remaining Hologic position as of Q4 2017 after selling out during the quarter.
  • Symphony Asset Management sold 23,613 Hologic shares in Q4 2017, an estimated $867K.
  • Symphony Asset Management first reported a position in Hologic in Q4 2013 and held it in 6 quarters.
  • Symphony Asset Management's Hologic position peaked at $4.36M in Q1 2016.
  • 472 funds tracked by Wall St. Rank held Hologic as of Q4 2017.

Based on Symphony Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.